Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.
about
In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography.Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model.Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET.Anti-CHMP5 single chain variable fragment antibody retrovirus infection induces programmed cell death of AML leukemic cells in vitroImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies).Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma.Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancerLevels of murine, but not human, CXCL13 are greatly elevated in NOD-SCID mice bearing the AIDS-associated Burkitt lymphoma cell line, 2F7Radiation Dosimetry Study of [(89)Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography.High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation.Advances in immuno-positron emission tomography: antibodies for molecular imaging in oncologyPositron emission tomography imaging of endometrial cancer using engineered anti-EMP2 antibody fragments.Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancersManaging lymphoma with non-FDG radiotracers: current clinical and preclinical applications.Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor.Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.Antibody vectors for imaging.Immuno-positron emission tomography in cancer models.Matched pairs dosimetry: 124I/131I metaiodobenzylguanidine and 124I/131I and 86Y/90Y antibodies.Engineered antibodies for molecular imaging of cancer.PET-based molecular imaging in personalized oncology: potential of the assessment of therapeutic outcome.Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.Radiolabelling rituximab with (99m)Tc in three steps procedure.Near-infrared fluorescence imaging of non-Hodgkin's lymphoma CD20 expression using Cy7-conjugated obinutuzumab.Metal-Based PSMA Radioligands.Production and characterization of a CD25-specific scFv-Fc antibody secreted from Pichia pastoris.First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.Positive progress in immunoPET--not just a coincidence.ImmunoPET of Malignant and Normal B Cells with 89Zr- and 124I-Labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization In Vivo.Expression of antibody fragments with a controlled N-glycosylation pattern and induction of endoplasmic reticulum-derived vesicles in seeds of Arabidopsis
P2860
Q22000844-9921C98C-84EF-4DAB-B1C3-6D468683F399Q30525314-6ECDF269-B13A-4398-9445-7C78E6874EE3Q30659434-E07A8BD0-EC99-43CA-ABB6-5D880BD299FEQ33567527-1AA6CC11-84C7-4EF6-A242-96A24299D003Q33738721-A7735E87-CC6A-4447-ADE9-57DD54B5305CQ33788697-6A4E3B6B-D055-4CAD-88E9-665A997E1F31Q34334475-6421645F-FA15-4EEE-9AAB-8DF0C1DCE889Q34927264-B8C9AB10-CE23-4540-927B-6D9C83DE946AQ35736289-6614AF3D-43B1-4E3B-8EF5-676C16849F96Q36211450-CF90240F-B28C-46DC-82B2-CD223CF858D5Q36339722-D43A3213-3025-436B-9448-ACA7C1614E7DQ36557471-C1AE5BAC-922C-453E-A3BE-2ECD1472B1B8Q36699195-AA01F951-D64C-4FFB-9877-7279C1D3A5BCQ36948431-63092EA3-455C-4695-957E-E10BECBE8477Q37138959-04E50D6B-26C1-4F6E-955E-4FCE3E9DC6E8Q37519517-C4B0A3D5-68FC-4596-A693-66AD099ACBEAQ37554230-13469071-8C31-46D5-BF89-16CA37A696C1Q37720850-A0D12897-5AB4-4EE4-8E6B-C04D376DAE0EQ37720853-6A98988C-E952-42FE-A671-1DB037D6CCA8Q37864159-6ED496D4-A7C2-49B0-8530-8736001F77CBQ38148881-8033E5D9-C378-48A1-94FE-94F6EB4951CBQ38389152-E5F8DAA7-8006-4ADB-8311-67A71A4AFB2CQ38795442-B729EAC9-A21C-4A88-BCF0-B813DA20AAAFQ38870324-279C66FE-9613-4C73-AC36-1BE0544C7E74Q38994546-9E01B46E-06EC-4410-A3B1-9FB9E7FDB732Q39198527-912CA6BD-D4B1-46F6-ACA6-6062BE0B39DEQ39224359-86D8A45C-447B-4501-AD06-293A3F8DC9FCQ40625131-1B55E1A1-2413-4486-BEF6-19DBA540BEA8Q41269380-4976E9B9-6167-48B2-A117-CF8CF8B3F3F4Q42429164-7D591C71-2093-4928-AC07-E6E726B040DCQ46060208-0E6816D9-AFFF-4F1B-BEDB-FEF252B60195Q56974525-0D1DD3C2-6C80-4CBE-A75B-E9AED9E134F4
P2860
Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Recombinant anti-CD20 antibody ...... T imaging of B-cell lymphomas.
@ast
Recombinant anti-CD20 antibody ...... T imaging of B-cell lymphomas.
@en
type
label
Recombinant anti-CD20 antibody ...... T imaging of B-cell lymphomas.
@ast
Recombinant anti-CD20 antibody ...... T imaging of B-cell lymphomas.
@en
prefLabel
Recombinant anti-CD20 antibody ...... T imaging of B-cell lymphomas.
@ast
Recombinant anti-CD20 antibody ...... T imaging of B-cell lymphomas.
@en
P2093
P2860
P1476
Recombinant anti-CD20 antibody ...... T imaging of B-cell lymphomas.
@en
P2093
Andrew A Raubitschek
David Betting
Felix B Salazar
John M Timmerman
Jonathan Said
Pat Clarke
Tove Olafsen
Vania E Kenanova
P2860
P304
P356
10.2967/JNUMED.108.060426
P407
P577
2009-08-18T00:00:00Z